10
Participants
Start Date
September 11, 2019
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
onabotulinum toxin A
Each subject will receive 50 units (50 U) of BoNT-A constituted in 1 mL of saline solution injected intraorally to the painful area divided in at least 3 sites, 0.5 to 1.0 cm apart depending on the size of the painful area and following a checkerboard pattern.
Orofacial Pain Center, Lexington
Collaborators (1)
AbbVie
INDUSTRY
Isabel Moreno Hay
OTHER